Browsing: AML
Acute myeloid leukemia (AML) is a type of blood cancer that forms in the soft bone marrow, usually attacking cells…
ABT199/venetoclax synergy with thiotepa enhances cytotoxicity of chemotherapeutic drugs in AML cells
A new research paper was published in Oncotarget’s Volume 15, on March 14, 2024, titled, “ABT199/venetoclax Synergy with Thiotepa Enhances…
The University of Texas MD Anderson Cancer Center and Rigel Pharmaceuticals, Inc. announced today a multi-year strategic development collaboration to…